NASDAQ:ESTA Establishment Labs Q3 2025 Earnings Report $41.92 +0.76 (+1.83%) As of 09:58 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast Establishment Labs EPS ResultsActual EPSN/AConsensus EPS -$0.54Beat/MissN/AOne Year Ago EPSN/AEstablishment Labs Revenue ResultsActual RevenueN/AExpected Revenue$52.28 millionBeat/MissN/AYoY Revenue GrowthN/AEstablishment Labs Announcement DetailsQuarterQ3 2025Date11/6/2025TimeBefore Market OpensConference Call DateThursday, November 6, 2025Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile Establishment Labs Earnings HeadlinesIs Establishment Labs Holdings Inc. (NASDAQ:ESTA) Expensive For A Reason? A Look At Its Intrinsic ValueOctober 12 at 10:00 AM | finance.yahoo.comCiti Sticks to Its Hold Rating for Establishment Labs Holdings (ESTA)October 12 at 4:59 AM | theglobeandmail.comThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. Right now, all seven are flashing red simultaneously for the first time since 2007. These aren't the signals you'll see on CNBC.October 14 at 2:00 AM | American Alternative (Ad)Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance ReportOctober 9, 2025 | finance.yahoo.comBrokerages Set Establishment Labs Holdings Inc. (NASDAQ:ESTA) PT at $56.50October 9, 2025 | americanbankingnews.comEstablishment Labs price target raised to $43 from $40 at CitiOctober 7, 2025 | msn.comSee More Establishment Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Establishment Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Establishment Labs and other key companies, straight to your email. Email Address About Establishment LabsEstablishment Labs (NASDAQ:ESTA) is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability. The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification. In addition to its core breast implant offerings, Establishment Labs is actively advancing a pipeline of complementary aesthetic and regenerative technologies aimed at expanding its footprint in minimally invasive and soft-tissue restoration procedures. Founded in Costa Rica in 2004, Establishment Labs has grown into an international enterprise with manufacturing facilities in Central America and distribution in more than 70 markets across North America, Latin America, Europe and the Asia-Pacific region. The company further broadened its capital access through a special purpose acquisition merger, resulting in its listing on the Nasdaq exchange in mid-2020. Leadership is anchored by founder and Executive Chairman Mauricio Cárdenas, whose entrepreneurial vision has guided the company since inception, alongside Chief Executive Officer Juan José Chacón, who oversees global operations, strategy and continued product innovation.View Establishment Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff Concerns Upcoming Earnings ASML (10/15/2025)Kinder Morgan (10/15/2025)Bank of America (10/15/2025)Prologis (10/15/2025)Abbott Laboratories (10/15/2025)Morgan Stanley (10/15/2025)The PNC Financial Services Group (10/15/2025)Progressive (10/15/2025)Interactive Brokers Group (10/16/2025)CSX (10/16/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
